metaPreg - Irbesartan (versus unexposed) during pregnancy

Irbesartan (versus unexposed) updated on 03-11-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)	3.40 [1.00, 11.53]	-	1 study	4,995	21	not evaluable	ROB	6.26 [1.05; .]
Major congenital malformations	3.40 [1.00, 11.53]	-	1 study	4,995	21	not evaluable	ROB	6.26 [1.05; .]